Digital Making sense of differing digital health funding reports Digital health venture funding had a ridiculous, bonkers, blockbuster year.
Views & Analysis US loses, EU wins as Chinese biotech investment shifts focus Chinese biotech investors are taking an interest in the European market as diplomatic relations with the US become strained.
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
